Alex Menchaca Presented at 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA

10.30.24

Alex recently spoke on “An In-Depth Look at 180-Day Exclusivity.” The session took a deep dive into the 180-day exclusivity, including “understanding 180-day generic market exclusivity under the Hatch-Waxman Act, identifying triggers for the running of the 180-day exclusivity period, deciphering the FDA’s new interpretation of pre- and post-MMA 180-day exclusivity” and more. This was part of ACI’s Proficiency Series, an immersive four-week course to learn vital industry concepts.